$MMSI

Merit Medical Systems (MMSI) will report earnings on Thursday. Last quarter, it beat revenue expectations with $418.8M, up 9.5% YoY. Analysts expect 6.8% YoY revenue growth this quarter. The stock is up 7.5% over the last month, with an average price target of $101.64.

Merit Medical (MMSI) reported Q2 revenue growth of 9%, raising full-year guidance and seeing a 4.5% stock increase. ICU Medical (ICUI) reported flat revenue but beat EPS estimates, with a 2.1% stock decline. Penumbra (PEN) saw 14.9% revenue growth but missed EPS estimates, with a flat stock. Artivion (AORT) reported 11.3% revenue growth and beat EPS estimates, but its stock fell 19.2%.

Merit Medical Systems (MMSI) will release Q3 2026 financial results on October 29, 2026, after market close, followed by an investor conference call at 4:30 p.m. ET. The company develops and distributes medical devices for various procedures, employing about 7,500 people globally.

Merit Medical Systems (MMSI) announced Sheri Lewis as EVP of Global Operations, replacing Mr. Peterson. Shares are at $90.68, up 6.67% in 30 days and 49.51% in 90 days. Analysts suggest a fair value of $100.27, implying a 9.6% undervaluation, but note a high P/E of 37.2x. The company's focus on operational efficiency and product expansion drives margin growth, though risks include reimbursement delays and trade issues.

Peterson Neil W. (CHIEF OPERATING OFFICER) sold 7,500 shares of MERIT MEDICAL SYSTEMS INC (MMSI) at $90.45 ($0.68M total) on 2026-08-24.

Merit Medical (MMSI) HR chief Michel J. Voigt gifted 650 shares of common stock as a charitable donation on 2026-08-24. Post-transaction, Voigt holds 45,412 direct shares and 2,265 indirect shares via a 401(k) plan. Voigt also holds non-qualified stock options on 17,542 shares with varying exercise prices and expiration dates.

Wolfpack Research reported Flotek Industries (FTK) lost a $400M contract, potentially halving its backlog. Fugazi Research criticized Aeva Technologies (AEVA) as a struggling startup. Bristlemoon Research argued Macy's (M) is overvalued. L3Harris (LHX) CEO departed over conduct violations. Ameresco (AMRC) CFO and GC resigned. Viking Therapeutics (VKTX) COO and Merit Medical (MMSI) COO departed. Boston Beer (SAM) CFO is stepping down. Edwin Dorsey predicts long-term trouble for DraftKings (DKNG)

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 ​ ​ ​ ​ ​ ​ Merit Medical Announces Global Operations Leadership Transition SOUTH JORDAN, Utah, August 19, 2026 (GLOBE NEWSWIRE) – Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has

Merit Medical Systems (MMSI) reported Q2 2026 sales of $418.84 million and net income of $38.8 million, and raised its full-year 2026 revenue outlook to $1.63 billion to $1.64 billion, according to the company. The article notes ongoing product recalls and reimbursement risks and mentions a 2029 narrative of about $1.8 billion revenue and $213.7 million earnings.

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.